Outcome of Relapse in Children/Adolescents with B-Cell Non-Hodgkin Lymphoma (B-NHL) and Mature Acute Leukemia (B-AL) Treated in the Rituximab (R) Era

被引：0
|
作者：
Rigaud, C. [1 ]
Auperin, A. [2 ]
Jourdain, A. [3 ]
Schmitt, C. [4 ]
Paillard, C. [5 ]
Couec, M. L. [6 ]
Aladjidi, N. [7 ]
Gandemer, V. [8 ]
Lambilliote, A. [9 ]
Plat, G. [10 ]
Michon, J. [11 ]
Leblanc, T. [12 ]
Patte, C. [1 ]
Minard-Colin, V. [1 ]
机构：
[1] Inst Gustave Roussy, Paediat Oncol, Villejuif, France
[2] Inst Gustave Roussy, Biostat, Villejuif, France
[3] Ctr Hosp Univ Tours, Paediat Oncol, Tours, France
[4] Ctr Hosp Univ Nancy, Paediat Oncol, Nancy, France
[5] Ctr Hosp Univ Strasbourg, Paediat Oncol, Strasbourg, France
[6] Ctr Hosp Univ Nantes, Paediat Haematol, Nantes, France
[7] Ctr Hosp Univ Bordeaux, Paediat Oncol, Bordeaux, France
[8] Ctr Hop Univ Rennes, Paediat Oncol, Rennes, France
[9] Ctr Hosp Univ Lille, Paediat Oncol, Lille, France
[10] Ctr Hosp Univ Toulouse, Paediat Oncol, Toulouse, France
[11] Inst Curie, Pedaitr Oncol, Paris, France
[12] Hop Robert Debre, AP HP, Paediat Haematol, Paris, France
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O-124
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] Where is the place for rituximab in the treatment of B-cell non-Hodgkin lymphoma (B-NHL) of children and adolescents?
    Patte, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 110 - 110
  • [2] Results of the Randomized Intergroup Trial Inter-B-NHL RITUX 2010 for Children/Adolescents with High-Risk B-Cell Non Hodgkin Lymphoma (B-NHL) and Mature Acute Leukemia (B-AL)
    Colin, V. Minard
    Auperin, A.
    Pillon, M.
    Burke, A.
    Anderson, J.
    Barkausk, D.
    Wheatley, K.
    Delgado, R.
    Alexander, S.
    Uyttebroeck, A.
    Bollard, C.
    Zsiros, J.
    Csoka, M.
    Goma, G.
    Tulard, A.
    Patte, C.
    Gross, T.
    PEDIATRIC BLOOD & CANCER, 2016, 63 : S31 - S31
  • [3] IN CHILDHOOD B-CELL NON HODGKIN LYMPHOMA (B-NHL) AND MATURE B-CELL ACUTE LEUKEMIA (B-AL) WITH CNS DISEASE AT DIAGNOSIS, PATIENTS WITH BLASTS IN CSF ARE AT HIGHER RISK OF EVENT
    Minard-Colin, Veronique
    Auperin, Anne
    Leverger, Guy
    Schmitt, Claudine
    Aladjidi, Nadia
    Michon, Jean
    Patte, Catherine
    PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 978 - 979
  • [4] IN CHILDHOOD B-CELL NON HODGKIN'S LYMPHOMA (B-NHL) AND MATURE B-CELL ACUTE LEUKEMIA (B-AL) WITH CNS DISEASE AT DIAGNOSIS, PATIENTS WITH BLASTS IN CSF ARE AT HIGHER RISK OF EVENT
    Minard-Colin, V.
    Auperin, A.
    Leverger, G.
    Schmitt, C.
    Aladjidi, N.
    Michon, J.
    Patte, C.
    ANNALS OF ONCOLOGY, 2011, 22 : 112 - 112
  • [5] In childhood B-cell non Hodgkin's lymphoma (B-NHL) and mature B-cell acute leukemia (B-AL) with CNS disease at diagnosis, patients with blasts in CSF are at higher risk of event
    Minard, V.
    Auperin, A.
    Leverger, G.
    Schmitt, C.
    Aladjidi, N.
    Michon, J.
    Patte, C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 : 43 - 43
  • [6] Results of the randomized Intergroup trial Inter-B-NHL Ritux 2010 for children and adolescents with high-risk B-cell non-Hodgkin lymphoma (B-NHL) and mature acute leukemia (B-AL): Evaluation of rituximab (R) efficacy in addition to standard LMB chemotherapy (CT) regimen.
    Minard-Colin, Veronique
    Auperin, Anne
    Pillon, Marta
    Burke, Amos
    Anderson, James Robert
    Barkauskas, Donald A.
    Wheatley, Keith
    Delgado, Rafael
    Alexander, Sarah
    Uyttebroeck, Anne
    Bollard, Catherine
    Zsiros, Jozsef
    Csoka, Monika
    Goma, Gisele
    Tulard, Anne
    Patte, Catherine
    Gross, Thomas G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Outcome of relapse in children and adolescents with B-cell non-Hodgkin lymphoma and mature acute leukemia: A report from the French LMB study
    Rigaud, Charlotte
    Auperin, Anne
    Jourdain, Anne
    Haouy, Stephanie
    Couec, Marie-Laure
    Aladjidi, Nathalie
    Gandemer, Virginie
    Lambliotte, Anne
    Plat, Genevieve
    Landman-Parker, Judith
    Michon, Jean
    Leblanc, Thierry
    Patte, Catherine
    Minard-Colin, Veronique
    PEDIATRIC BLOOD & CANCER, 2019, 66 (09)
  • [8] Safety, Efficacy and Rituximab Levels Following Chemoimmunotherapy (Rituximab plus FAB Chemotherapy) in Children and Adolescents with Mature B-Cell Non-Hodgkin Lymphoma (B-NHL): A Children's Oncology Group Report
    Cairo, Mitchell S.
    Lynch, James
    Harrison, Lauren
    van de Ven, Carmella
    Gross, Thomas
    Shiramizu, Bruce
    Sanger, Warren
    Perkins, Sherrie L.
    Goldman, Stanton
    BLOOD, 2008, 112 (11) : 310 - 310
  • [9] TANDEM AUTOLOGOUS ALLOGENEIC STEM CELL TRANSPLANTATION IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED/REFRACTORY MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL)
    Gardenswartz, A.
    Mehta, B.
    El-Mallawany, N.
    van de Ven, C.
    Hochberg, J.
    Flower, A.
    Morris, E.
    Harrison, L.
    Basso, J.
    Gerard, P.
    Ayello, J.
    Baxter-Lowe, L. A.
    Cairo, M. S.
    PEDIATRIC BLOOD & CANCER, 2019, 66
  • [10] MINIMAL DISSEMINATED DISEASE/RESIDUAL DISEASE IN CHILDREN AND ADOLESCENTS WITH MATURE B-CELL NON-HODGKIN LYMPHOMA (B-NHL) MAY IMPACT THE RISK OF RELAPSE: A CHILDREN'S ONCOLOGY GROUP REPORT
    Shiramizu, B.
    Goldman, S.
    Smith, L.
    Harrison, L.
    Van De Ven, C.
    Gross, T. G.
    Sanger, W.
    Perkins, S.
    Cairo, M. S.
    ANNALS OF ONCOLOGY, 2011, 22 : 114 - 114
12345